Namsung Expands Mobility AI DEVICE Business Based on North American Distribution Network
Targeting the North American Market by Leveraging Its Own Brand and 20 Years of Local Logistics Infrastructure
Pushing Ahead with a Mobility Business Combining AI Services, Led by 'NS AI LINK'
[Edaily Reporter Hyera Lee ] Namsung(004270), a company specializing in automotive AI solutions, announced on the 14th that it will expand its mobility AI DEVICE business based on the electronics and automotive electronics technologies it has accumulated over the past 60 years, as well as its North American distribution and logistics infrastructure. Namsung AI. (Photo courtesy of Namsung) The company has been operating in the North American car infotainment market under its own brands—“Dual,” “Jensen,” and “Axxera”—and plans to expand its business, which has centered on in-vehicle audio and video, into the AI device and service sectors. Through its U.S. subsidiary, Namsung supplies products to Walmart, Advance Auto Parts, and O’Reilly Auto Parts, and also sells automotive products on Amazon and Walmart.com. The company operates third-party logistics (3PL) hubs in Reno, Nevada, and Illinois, and has established a local logistics and supply chain management system. The company intends to leverage these North American distribution and logistics capabilities to launch its in-vehicle AI DEVICE, “NS AI LINK,” into the local market. NS AI LINK is a DEVICE that connects generative AI and AI agents in vehicles and smartphones to provide various in-vehicle AI services. Namsung plans to secure a sales network centered on its existing offline partners before expanding distribution to online channels, and intends to strengthen its mobility business by integrating personalized AI services such as shopping and advertising in the future. A Namsung official stated, “We will leverage the North American distribution and logistics infrastructure we have built over the past 20 years to cultivate NS AI LINK as a new growth engine.”
This week (July 13–16), startups across various sectors—including beauty brands, chat platforms, and AI-based decision-making and data infrastructure—secured investments from venture capital (VC) firm…
Here are the clinical trial and product approval updates that garnered attention in the domestic pharmaceutical and biotech industry this week (July 13–16).
(Photo: AI-generated)
CelltrionRece…
PharmaResearch(214450)is staking its future on expanding into North America—the world’s largest beauty market—despite concerns over stagnant growth in its domestic market. At the same time, attention …